Mainz Biomed Bv Stock Cash Flow From Operations

MYNZ Stock

USD 0.23 0.02 9.52%

Mainz Biomed BV fundamentals help investors to digest information that contributes to Mainz Biomed's financial success or failures. It also enables traders to predict the movement of Mainz Stock. The fundamental analysis module provides a way to measure Mainz Biomed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mainz Biomed stock.

Short Long Term Debt Total Total Assets

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Mainz Biomed BV Company Cash Flow From Operations Analysis

Mainz Biomed's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.

Operating Cash Flow

EBITDA

-

Taxes

More About Cash Flow From Operations | All Equity Analysis

Current Mainz Biomed Cash Flow From Operations

(21.94 M)

Most of Mainz Biomed's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mainz Biomed BV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Mainz Cash Flow From Operations Driver Correlations

Understanding the fundamental principles of building solid financial models for Mainz Biomed is extremely important. It helps to project a fair market value of Mainz Stock properly, considering its historical fundamentals such as Cash Flow From Operations. Since Mainz Biomed's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Mainz Biomed's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Mainz Biomed's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Total Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Capital Stock	Net Working Capital	Short Term Debt	Common Stock	Net Tangible Assets	Property Plant Equipment	Intangible Assets
Total Assets		0.94	0.93	-0.83	-0.85	0.83	0.72	0.8	0.79	0.99	0.63	0.98	0.87	0.73	0.65	0.87	0.93	-0.83	-0.46
Total Stockholder Equity	0.94		0.93	-0.96	-0.67	0.65	0.72	0.62	0.54	0.97	0.4	0.99	0.65	0.9	0.42	0.65	0.85	-0.69	-0.28
Current Deferred Revenue	0.93	0.93		-0.86	-0.7	0.71	0.9	0.6	0.64	0.94	0.47	0.95	0.76	0.81	0.49	0.76	0.92	-0.77	-0.33
Net Debt	-0.83	-0.96	-0.86		0.43	-0.41	-0.64	-0.38	-0.33	-0.88	-0.12	-0.92	-0.45	-0.99	-0.15	-0.45	-0.68	0.45	0.0
Retained Earnings	-0.85	-0.67	-0.7	0.43		-0.99	-0.57	-0.98	-0.91	-0.8	-0.94	-0.75	-0.94	-0.28	-0.95	-0.94	-0.9	0.96	0.84
Accounts Payable	0.83	0.65	0.71	-0.41	-0.99		0.62	0.96	0.88	0.78	0.95	0.74	0.92	0.27	0.96	0.92	0.92	-0.99	-0.87
Long Term Debt	0.72	0.72	0.9	-0.64	-0.57	0.62		0.41	0.49	0.71	0.42	0.74	0.62	0.61	0.43	0.62	0.86	-0.73	-0.37
Net Receivables	0.8	0.62	0.6	-0.38	-0.98	0.96	0.41		0.87	0.76	0.94	0.7	0.88	0.23	0.95	0.88	0.82	-0.91	-0.84
Total Liab	0.79	0.54	0.64	-0.33	-0.91	0.88	0.49	0.87		0.73	0.85	0.65	0.98	0.2	0.86	0.98	0.78	-0.82	-0.63
Net Invested Capital	0.99	0.97	0.94	-0.88	-0.8	0.78	0.71	0.76	0.73		0.56	0.99	0.81	0.79	0.59	0.81	0.91	-0.78	-0.4
Short Long Term Debt	0.63	0.4	0.47	-0.12	-0.94	0.95	0.42	0.94	0.85	0.56		0.5	0.85	-0.04	1.0	0.85	0.76	-0.91	-0.94
Total Current Assets	0.98	0.99	0.95	-0.92	-0.75	0.74	0.74	0.7	0.65	0.99	0.5		0.75	0.85	0.52	0.75	0.9	-0.76	-0.37
Capital Stock	0.87	0.65	0.76	-0.45	-0.94	0.92	0.62	0.88	0.98	0.81	0.85	0.75		0.32	0.86	1.0	0.88	-0.89	-0.65
Net Working Capital	0.73	0.9	0.81	-0.99	-0.28	0.27	0.61	0.23	0.2	0.79	-0.04	0.85	0.32		-0.01	0.32	0.57	-0.32	0.14
Short Term Debt	0.65	0.42	0.49	-0.15	-0.95	0.96	0.43	0.95	0.86	0.59	1.0	0.52	0.86	-0.01		0.86	0.77	-0.92	-0.94
Common Stock	0.87	0.65	0.76	-0.45	-0.94	0.92	0.62	0.88	0.98	0.81	0.85	0.75	1.0	0.32	0.86		0.88	-0.89	-0.65
Net Tangible Assets	0.93	0.85	0.92	-0.68	-0.9	0.92	0.86	0.82	0.78	0.91	0.76	0.9	0.88	0.57	0.77	0.88		-0.95	-0.67
Property Plant Equipment	-0.83	-0.69	-0.77	0.45	0.96	-0.99	-0.73	-0.91	-0.82	-0.78	-0.91	-0.76	-0.89	-0.32	-0.92	-0.89	-0.95		0.86
Intangible Assets	-0.46	-0.28	-0.33	0.0	0.84	-0.87	-0.37	-0.84	-0.63	-0.4	-0.94	-0.37	-0.65	0.14	-0.94	-0.65	-0.67	0.86

Click cells to compare fundamentals

Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.

Competition

Predict Mainz Biomed

Total Cash From Operating Activities Over Time

In accordance with the recently published financial statements, Mainz Biomed BV has (21.94 Million) in Cash Flow From Operations. This is 104.16% lower than that of the Biotechnology sector and 109.56% lower than that of the Health Care industry. The cash flow from operations for all United States stocks is 102.26% higher than that of the company.

Mainz Cash Flow From Operations Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mainz Biomed's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Mainz Biomed could also be used in its relative valuation, which is a method of valuing Mainz Biomed by comparing valuation metrics of similar companies.

Mainz Biomed is currently under evaluation in cash flow from operations category among its peers.

Mainz Fundamentals

	Return On Equity	-43.34
	Return On Asset	-0.99
	Operating Margin	(18.83) %
	Current Valuation	21.7 M
	Shares Outstanding	64.04 M
	Shares Owned By Insiders	20.21 %
	Shares Owned By Institutions	0.88 %
	Number Of Shares Shorted	1.52 M
	Price To Book	1.72 X
	Price To Sales	15.71 X
	Revenue	895.48 K
	Gross Profit	177.62 K
	EBITDA	(25.01 M)
	Net Income	(26.3 M)
	Cash And Equivalents	26.01 M
	Cash Per Share	1.80 X
	Total Debt	7.42 M
	Debt To Equity	0.10 %
	Current Ratio	10.83 X
	Book Value Per Share	(0.16) X
	Cash Flow From Operations	(21.94 M)
	Short Ratio	0.76 X
	Earnings Per Share	(1.11) X
	Target Price	2.0
	Number Of Employees	65
	Beta	0.076
	Market Capitalization	14.41 M
	Total Asset	15.41 M
	Retained Earnings	(69.33 M)
	Working Capital	(257.15 K)
	Net Asset	15.41 M

About Mainz Biomed Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Mainz Biomed BV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mainz Biomed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mainz Biomed BV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for Mainz Stock Analysis

When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC